Santen to be recognized with award from Glaucoma Research Foundation

Santen Pharmaceutical Co. will receive the Glaucoma Research Foundation’s Catalyst Award, the organization’s highest distinction. 

Advertisement

Santen, which specializes solely in eye care, will receive the award at the Glaucoma 360 Annual Gala in February, according to a Jan. 26 news release.

“Santen is extremely proud and honored to receive this prestigious award,” Peter Sallstig, MD, the global head of Santen’s product development division and chief medical officer. “Our team is guided by a passion for bringing innovation to eye care and contributing to the well-being of patients and their families worldwide.”

The two organizations began working together in 2012.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.